Increased cystatin C immunoreactivity in the skin in amyotrophic lateral sclerosis

Acta Neurologica Scandinavica

Volumn 102, Issue 1, 2000, Pages 47-52

  Ono, Seiitsu ^a   Shimizu, N ^a   Imai, T ^b   Mihori, A ^a   Nagao, K ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chiba Higashi Hospital   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Cystatin C; Immunohistochemistry; Skin

Indexed keywords

CYSTATIN C;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; OPTICAL DENSITY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SKIN;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODIES; BIOPSY; CYSTATINS; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

EID: 0034047408     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.102001047.x     Document Type: Article

References (29)

1. 1. GRUBB A, LÖFBERG H. Human γ-trace, a basic microprotein: its amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982;79:3024-7.
2. 2. BARRETT AJ, DAVIES ME, CRUBB A. The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun 1984;120:631-6.
3. 3. HUISMAN W, LANTING L, DODDEMA HJ, BOUMA JMW, GRUBER M. Role of individual cathepsins in lysosomal protein digestion as tested by specific inhibitors. Biochim Biophys Acta 1974;370:297-307.
4. 4. MÖLLER CA, LÖFBERG H, GRUBB AO, OLSSON SO, DAVIES ME, BARRETT AJ. Distribution of cystatin C (γ-trace), an inhibitor of lysosomal cysteine proteases, in the anterior lobe of simian and human pituitary glands. Neuroendocrinology 1985;41:400-4.
5. 5. LÖFBERG H, GRUBB AO. Quantification of γ-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 1979;39:619-26.
6. 6. HOCHWALD GM, THORBECKE GJ. Abnormal metabolism or reduced transport of CSF γ-trace microprotein in hereditary cerebral hemorrhage with amyloidosis. New Engl J Med 1985;312:1127-8.
7. 7. PALSDOTTIR A, ABRAHAMSON M, THORSTEINSSON L et al. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 1988;II:603-4.
8. 8. OKAMOTO K, HIRAI S, AMARI M, WATANABE M, SAKURAI A. Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum. Neurosci Lett 1993;162:125-8.
9. 9. PROVINCIALI L, CANGIOTTI A, TULLI D, CARBONI V, CINTI S. Skin abnormalities and autonomic involvement in the early stage of amyotrophic lateral sclerosis. J Neurol Sci 1994;126:54-61.
10. 10. ONO S, IMAI T, ASO A, YAMANO T, SHIMIZU N, NAGAO K. Alterations of skin glycosaminoglycans in patients with ALS. Neurology 1998;51:399-404.
11. 11. ONO S, YAMAUCHI M. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis. Ann Neurol 1992;31:305-10.
12. 12. ONO S, MECHANIC GL, YAMAUCHI M. Amyotrophic lateral sclerosis: unusually low content of collagen in skin. J Neurol Sci 1990;100:234-7.
13. 13. BROOKS BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):96-107.
14. 14. CAROSCIO JT, COHEN JA, ZAWODNIAK J et al. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis. Neurology 1986;16:141-5.
15. 15. PATTEN BM, HARATI Y, ACOSTA L, JUNG SS, FFIMUS MT. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol 1978;3:305-9.
16. 16. HSU SM, RAINE L, FANGER H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
17. 17. ABRAHAMSON M, BARRETT AJ, SALVESEN G, GRUBB A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem 1986;261:11282-9.
18. 18. TAVERA C, PREVOT D, GIROLAMI JP, LEUNG-TACK J, COLLE A. Tissue and biological fluid distribution of cysteine proteinases inhibitor: rat cystatin C. Biol Chem Hoppe Seyler 1990;371(suppl):187-92.
19. 19. LÖFBERG H, GRUBB AO, BRUN A. Human brain cortical neurons contain γ-trace. Rapid isolation, immunohistochemical and physicochemical characterization of human γ-trace. Biomed Res 1981;2:298-306.
20. 20. BENEDIKZ E, BLONDAL H, JOHANNESSON G, GUOMUNDSSON G. Dementia with non-hereditary cystatin C angiopathy. Prog Clin Biol Res 1989;317:517-22.
21. 21. YASUHARA O, HANAI K, OHKUBO I, SASAKI M, MCGEER PL, KIMURA H. Expression of cystatin C in rat, monkey and human brains. Brain Res 1993;628:85-92.
22. 22. WARFEL AH, ZUCKER-FRANKLIN D, FRANGIONIE B, GHISO J. Constitutive secretion of cystatin C (γ-trace) by monocytes and macrophages and its downregulation after stimulation. J Exp Med 1987;166:1912-17.
23. 23. ZUCKER-FRANKLIN D, WARFEL A, GRUSKY G, FRANGIONE B, TEITEL D. Novel monocyte-like properties of microglial/astroglial cells; Constitutive secretion of lysozyme and cystatin C. Lab Invest 1987;57:176-85.
24. 2-microglobulin in rat brain. Eur J Biochem 1989;186:35-42.
25. 25. BUTTLE DJ, BURNETT D, ABRAHAMSON M. Levels of neutrophil elastase and cathepsin B activities and cystatins in human sputum: relationship to inflammation. Scand J Clin Lab Invest 1990;50:509-16.
26. 26. LEUNG-TACK J, TAVERA C, GENSAC MC, MARTINEZ J, COLLE A. Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg. Exp Cell Res 1990;188:16-22.
27. 27. BJÖRCK L, AKESSON P, BOHUS M et al. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 1989;337:385-6.
28. 28. BJÖRCK L, GRUBB A, KJFLLEN L. Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol 1990;64:941-3.
29. 29. ONO S, IMAI T, SHIMIZU N, NAKAGAWA H, HU J. Ciliary neurotrophic factor in skin biopsies of patients with amyotrophic lateral sclerosis. Lancet 1998;352:958-9.